These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33939331)

  • 1. More severe phenotype of early-onset osteoporosis associated with recessive form of LRP5 and combination with DKK1 or WNT3A.
    Caetano da Silva C; Ricquebourg M; Orcel P; Fabre S; Funck-Brentano T; Cohen-Solal M; Collet C
    Mol Genet Genomic Med; 2021 Jun; 9(6):e1681. PubMed ID: 33939331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Phenotype and Relevance of LRP5 and LRP6 Variants in Patients With Early-Onset Osteoporosis (EOOP).
    Stürznickel J; Rolvien T; Delsmann A; Butscheidt S; Barvencik F; Mundlos S; Schinke T; Kornak U; Amling M; Oheim R
    J Bone Miner Res; 2021 Feb; 36(2):271-282. PubMed ID: 33118644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare variations in WNT3A and DKK1 may predispose carriers to primary osteoporosis.
    Korvala J; Löija M; Mäkitie O; Sochett E; Jüppner H; Schnabel D; Mora S; Cole WG; Ala-Kokko L; Männikkö M
    Eur J Med Genet; 2012 Oct; 55(10):515-9. PubMed ID: 22789636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-Onset Osteoporosis: Rare Monogenic Forms Elucidate the Complexity of Disease Pathogenesis Beyond Type I Collagen.
    Costantini A; Mäkitie RE; Hartmann MA; Fratzl-Zelman N; Zillikens MC; Kornak U; Søe K; Mäkitie O
    J Bone Miner Res; 2022 Sep; 37(9):1623-1641. PubMed ID: 35949115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity.
    Korvala J; Jüppner H; Mäkitie O; Sochett E; Schnabel D; Mora S; Bartels CF; Warman ML; Deraska D; Cole WG; Hartikka H; Ala-Kokko L; Männikkö M
    BMC Med Genet; 2012 Apr; 13():26. PubMed ID: 22487062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signaling.
    Balemans W; Devogelaer JP; Cleiren E; Piters E; Caussin E; Van Hul W
    J Bone Miner Res; 2007 May; 22(5):708-16. PubMed ID: 17295608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WNT11, a new gene associated with early onset osteoporosis, is required for osteoblastogenesis.
    Caetano da Silva C; Edouard T; Fradin M; Aubert-Mucca M; Ricquebourg M; Raman R; Salles JP; Charon V; Guggenbuhl P; Muller M; Cohen-Solal M; Collet C
    Hum Mol Genet; 2022 May; 31(10):1622-1634. PubMed ID: 34875064
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Fabre S; Bourmaud M; Mabilleau G; Goulet R; Couturier A; Dentel A; Picaud S; Funck-Brentano T; Collet C; Cohen-Solal M
    JBMR Plus; 2023 Jun; 7(6):e10741. PubMed ID: 37283650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of genetic polymorphisms in WNT signaling pathway (
    Huang Q; Wang CC; Liu YG; Zhao CM; Zhang TP; Liu Y; Wang H
    Front Immunol; 2022; 13():1011700. PubMed ID: 36569862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men.
    Kiel DP; Ferrari SL; Cupples LA; Karasik D; Manen D; Imamovic A; Herbert AG; Dupuis J
    Bone; 2007 Mar; 40(3):587-96. PubMed ID: 17137849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis.
    van Meurs JB; Trikalinos TA; Ralston SH; Balcells S; Brandi ML; Brixen K; Kiel DP; Langdahl BL; Lips P; Ljunggren O; Lorenc R; Obermayer-Pietsch B; Ohlsson C; Pettersson U; Reid DM; Rousseau F; Scollen S; Van Hul W; Agueda L; Akesson K; Benevolenskaya LI; Ferrari SL; Hallmans G; Hofman A; Husted LB; Kruk M; Kaptoge S; Karasik D; Karlsson MK; Lorentzon M; Masi L; McGuigan FE; Mellström D; Mosekilde L; Nogues X; Pols HA; Reeve J; Renner W; Rivadeneira F; van Schoor NM; Weber K; Ioannidis JP; Uitterlinden AG;
    JAMA; 2008 Mar; 299(11):1277-90. PubMed ID: 18349089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders.
    Levasseur R; Lacombe D; de Vernejoul MC
    Joint Bone Spine; 2005 May; 72(3):207-14. PubMed ID: 15850991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Rare
    Rocca MS; Minervini G; Di Nisio A; Merico M; Bueno Marinas M; De Toni L; Pilichou K; Garolla A; Foresta C; Ferlin A
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A1330V variant of the low-density lipoprotein receptor-related protein 5 (LRP5) gene decreases Wnt signaling and affects the total body bone mineral density in Japanese women.
    Urano T; Shiraki M; Usui T; Sasaki N; Ouchi Y; Inoue S
    Endocr J; 2009; 56(4):625-31. PubMed ID: 19571442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Homozygous LRP5 Mutations in Mexican Patients with Osteoporosis-Pseudoglioma Syndrome.
    Astiazarán MC; Cervantes-Sodi M; Rebolledo-Enríquez E; Chacón-Camacho O; Villegas V; Zenteno JC
    Genet Test Mol Biomarkers; 2017 Dec; 21(12):742-746. PubMed ID: 29131652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-Onset Osteoporosis: Molecular Analysis in Large Cohort and Focus on the PLS3 Gene.
    Mancini M; Chapurlat R; Isidor B; Desjonqueres M; Couture G; Guggenbuhl P; Coutant R; El Chehadeh S; Fradin M; Frazier A; Goldenberg A; Guillot P; Koumakis E; Mehsen-Cêtre N; Rossi M; Schaefer É; Sigaudy S; Porquet-Bordes V; Fontanges É; Letard P; Edouard T; Javier RM; Cohen-Solal M; Funck-Brentano T; Collet C
    Calcif Tissue Int; 2024 Nov; 115(5):591-598. PubMed ID: 39316135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lrp5 Mutant and Crispant Zebrafish Faithfully Model Human Osteoporosis, Establishing the Zebrafish as a Platform for CRISPR-Based Functional Screening of Osteoporosis Candidate Genes.
    Bek JW; Shochat C; De Clercq A; De Saffel H; Boel A; Metz J; Rodenburg F; Karasik D; Willaert A; Coucke PJ
    J Bone Miner Res; 2021 Sep; 36(9):1749-1764. PubMed ID: 33957005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New explanation for autosomal dominant high bone mass: Mutation of low-density lipoprotein receptor-related protein 6.
    Whyte MP; McAlister WH; Zhang F; Bijanki VN; Nenninger A; Gottesman GS; Lin EL; Huskey M; Duan S; Dahir K; Mumm S
    Bone; 2019 Oct; 127():228-243. PubMed ID: 31085352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Er-Zhi-Wan on microarchitecture and regulation of Wnt/β-catenin signaling pathway in alveolar bone of ovariectomized rats.
    Sun W; Wang YQ; Yan Q; Lu R; Shi B
    J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):114-119. PubMed ID: 24496689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WNT3A gene polymorphisms are associated with bone mineral density variation in postmenopausal mestizo women of an urban Mexican population: findings of a pathway-based high-density single nucleotide screening.
    Velázquez-Cruz R; García-Ortiz H; Castillejos-López M; Quiterio M; Valdés-Flores M; Orozco L; Villarreal-Molina T; Salmerón J
    Age (Dordr); 2014 Jun; 36(3):9635. PubMed ID: 24584697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.